These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32215341)

  • 1. Serum KL-6 elevation in a uveitis patient with Behçet's disease treated with adalimumab.
    Ono T; Iwasaki T; Terada Y; Abe K; Lee J; Mochizuki M; Miyata K
    Am J Ophthalmol Case Rep; 2020 Jun; 18():100660. PubMed ID: 32215341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early administration of adalimumab for paediatric uveitis due to Behçet's disease.
    Hiyama T; Harada Y; Doi T; Kiuchi Y
    Pediatr Rheumatol Online J; 2019 Jun; 17(1):29. PubMed ID: 31182107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adalimumab in Treatment of Uveitis in Pediatric Behcet's Disease-a Case Report.
    Halilbasic M; Vodencarevic AN; Cosickic A; Halilbasic A; Cabric A
    Mater Sociomed; 2021 Mar; 33(1):78-81. PubMed ID: 34012357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-α2a treatment for refractory Behçet's disease.
    Lai YJ; Chan WC
    Taiwan J Ophthalmol; 2018; 8(3):168-172. PubMed ID: 30294531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological agent in prevention of ocular recurrence in Behçets disease: a case report.
    Adnan IA; Kharelo SR; Biswas J
    Nepal J Ophthalmol; 2019 Jul; 11(22):218-222. PubMed ID: 32792699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Panuveitis with oral and genital ulcer misdiagnosed as Behcet's disease: two cases report and literature review].
    Wang Y; Yang L; Zhang ZL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):910-914. PubMed ID: 27752180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.
    Interlandi E; Leccese P; Olivieri I; Latanza L
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S58-62. PubMed ID: 25005224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked improvement in gastric involvement in Behçet's disease with adalimumab treatment.
    Sonoda A; Ogawa R; Mizukami K; Fukuda K; Shuto M; Okamoto K; Matsunari O; Okimoto T; Murakami K
    Turk J Gastroenterol; 2017 Sep; 28(5):405-407. PubMed ID: 28797990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of serum Krebs von den Lunge-6 levels in patients with tubulointerstitial nephritis and uveitis syndrome.
    Kase S; Kitaichi N; Namba K; Miyazaki A; Yoshida K; Ishikura K; Ikeda M; Nakashima T; Ohno S
    Am J Kidney Dis; 2006 Dec; 48(6):935-41. PubMed ID: 17162148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet's disease-related uveitis.
    Ho M; Chen LJ; Sin HPY; Iu LPL; Brelen M; Ho ACH; Lai TYY; Young AL
    J Ophthalmic Inflamm Infect; 2019 Jul; 9(1):14. PubMed ID: 31367810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet's Disease.
    Kaji M; Kishi T; Miyamae T; Nagata S; Yamanaka H; Fujikawa S
    Case Rep Rheumatol; 2015; 2015():716138. PubMed ID: 26609459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease.
    Ma H; Lu J; Song Y; Wang H; Yin S
    BMC Pulm Med; 2020 Jan; 20(1):6. PubMed ID: 31915006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elusive diagnosis of Behcet's disease in setting of painless vision loss.
    Patel AA; Stutman A; Patel P; Capoccia M
    SAGE Open Med Case Rep; 2020; 8():2050313X20981460. PubMed ID: 33403115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
    Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
    Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orbital myositis as an initial manifestation of Behcet's disease.
    Abe S; Yunoki T; Hayashi A
    Am J Ophthalmol Case Rep; 2022 Sep; 27():101630. PubMed ID: 35845748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective treatment of refractory sympathetic ophthalmia with glaucoma using adalimumab.
    Hiyama T; Harada Y; Kiuchi Y
    Am J Ophthalmol Case Rep; 2019 Jun; 14():1-4. PubMed ID: 30766937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Krebs von den Lungen-6 levels in psoriatic patients under treatment with biologics.
    Iwata H; Haga N; Sugai T; Fujita Y
    J Dermatol; 2021 Mar; 48(3):376-379. PubMed ID: 33146900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of neuro-Behçet's disease triggered by herpes zoster-associated uveitis].
    Okamoto N; Ogawa N; Kitamura A; Yamakawa I; Kim H; Urushitani M
    Rinsho Shinkeigaku; 2021 Sep; 61(9):640-645. PubMed ID: 34433748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Anti-Tumor Necrosis Factor-α Therapy Against Intestinal Behçet's Disease Complicated by Recurrent Enterocutaneous Fistulae.
    Kashima H; Matsumoto S; Kojima S; Koito Y; Miura T; Ishii T; Mashima H
    Biologics; 2022; 16():1-6. PubMed ID: 35140458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum KL-6 elevation and possible pulmonary involvement in patients with rheumatoid arthritis treated with biological agents.
    Takahashi K; Nakamura H; Takenouchi K; Iizawa N; Koiwa M; Sato A; Mochizuki Y; Watanabe H; Takai S
    J Nippon Med Sch; 2014; 81(6):364-71. PubMed ID: 25744479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.